| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | ADDvise Group AB (publ): Delisting of the shares and warrants in ADDvise from Nasdaq First North | 56 | GlobeNewswire (Europe) | On 29 January 2026, ADDvise Group AB (publ) ("ADDvise") announced that its board of directors had applied for delisting of the shares and warrants in ADDvise from Nasdaq First North Premier Growth Market... ► Artikel lesen | |
| 29.01. | ADDvise Group AB (publ): ADDvise has applied for delisting of its shares and warrants from Nasdaq First North | 103 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex"), announced a public offer (the "Offer") to the holders of shares and warrants of ADDvise Group AB (publ) ("ADDvise"). On 27 January 2026, Amplex announced that... ► Artikel lesen | |
| 27.01. | Amplex AB becomes the owner of 94.31 per cent of the shares in ADDvise, extends the acceptance period and intends to initiate compulsory redemption and promote delisting | 1 | Cision News | ||
| 19.01. | Amplex AB has obtained all approvals from authorities for the offer to the shareholders and warrantholders of ADDvise Group AB (publ) and declares the offer unconditional | 1 | Cision News | ||
| 14.01. | ADDvise Group AB (publ): ADDvise announces financial update for 2025 | 93 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the holders of shares and warrants in ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all their... ► Artikel lesen | |
| ADDVISE GROUP Aktie jetzt für 0€ handeln | |||||
| 05.01. | ADDvise Group AB (publ): Statement from the independent bid committee of ADDvise in relation to the public offer from Amplex | 144 | GlobeNewswire (Europe) | The independent bid committee of ADDvise recommends that holders of shares and warrants who have a short-term perspective on their ownership or who do not wish to be owners in a listed ADDvise with... ► Artikel lesen | |
| 02.01. | ADDvise Group AB (publ): ADDvise initiates a written procedure under its outstanding bonds 2025/2028 in light of the public offer from Amplex | 298 | GlobeNewswire (Europe) | ADDvise Group AB (publ) (the "Company" or "ADDvise") has instructed the agent under the Company's outstanding bonds 2025/2028 with ISIN SE0025011885 (the "Bonds") to initiate a written procedure in... ► Artikel lesen | |
| 30.12.25 | AMPLEX AB: Amplex enters into additional agreements on conditional acquisitions of shares and warrants in ADDvise | 2 | Cision News | ||
| 19.12.25 | ADDvise Group AB (publ): Amplex has increased the consideration in the public offer to the shareholders and warrant holders of ADDVise | 90 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all shares... ► Artikel lesen | |
| 19.12.25 | Amplex AB publishes supplement to the offer document regarding the cash offer to the shareholders and warrantholders of ADDvise Group AB (publ) | 1 | Cision News | ||
| 19.12.25 | AMPLEX AB: Amplex increases the consideration in the cash offer to the shareholders and warrantholders of ADDvise and enters into agreements on conditional acquisitions of shares and warrants in ADDvise | 3 | Cision News | ||
| 10.12.25 | ADDvise Group AB (publ) receives observation status | 327 | GlobeNewswire | Today, December 10, 2025, Amplex AB disclosed a public offer to the other shareholders and equity rights holders of ADDvise Group AB (publ).
The rules of Nasdaq First North Growth Market state... ► Artikel lesen | |
| 10.12.25 | AMPLEX AB: Amplex publishes the offer document for the public cash offer to the shareholders and warrantholders of ADDvise Group AB (publ) | 4 | Cision News | ||
| 10.12.25 | Amplex AB announces a cash offer to the shareholders and warrantholders of ADDvise Group AB (publ) | 7 | Cision News | ||
| 10.12.25 | ADDvise Group AB (publ): ADDvise's board of directors evaluates the public offer from Amplex | 178 | GlobeNewswire (Europe) | Amplex AB ("Amplex") has today announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise") to transfer all shares and warrants in ADDvise to Amplex at a price... ► Artikel lesen | |
| 12.11.25 | ADDvise Group AB (publ): ADDvise receives order worth USD 2.3 million | 160 | GlobeNewswire (Europe) | ADDvise Group's subsidiary MRC Systems has received an order from IPS. IPS are a global engineering firm that delivers complex projects within life science. The order is worth approximately USD 2.3... ► Artikel lesen | |
| 23.10.25 | ADDvise Group AB (publ): Interim report 2025, January 1-September 30 | 150 | GlobeNewswire (Europe) | Strengthened profitability and cash flow despite a quarter with macro headwinds. In the third quarter, organic sales decreased by 4.8% in constant currency, but the year-to-date growth remains positive.... ► Artikel lesen | |
| 17.07.25 | ADDvise Group AB (publ): Interim report 2025, January 1-June 30 | 181 | GlobeNewswire (Europe) | In the second quarter of 2025, organic sales adjusted for currency effects increased, driven by steady demand for laboratory equipment and rental of equipment for clinical studies. Operating cash flow... ► Artikel lesen | |
| 26.05.25 | ADDvise Group AB (publ): ADDvise enters into facilities agreement with Nordea - reduces financial costs by approximately SEK 56 million per year | 1.605 | GlobeNewswire (Europe) | ADDvise Group AB (publ) has entered into a new secured facilities agreement with Nordea Bank Abp, filial i Sverige, with a total limit of SEK 450 million. As previously communicated, the company will... ► Artikel lesen | |
| 12.05.25 | ADDvise Group AB (publ): Johan Irwe is appointed CFO, Staffan Torstensson (also CEO) assumes role as Head of the Healthcare segment, and Fredrik Mella departs | 180 | GlobeNewswire (Europe) | Since July 2024, Johan Irwe has served as interim CFO and has delivered strong results in the role. With his sharp analytical skills and dedicated leadership, Johan has created significant value for... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | DAX-Konzern Siemens Healthineers legt Zahlen vor | Siemens Healthineers startet solide ins neue Geschäftsjahr und bestätigt den Jahresausblick, wird aber vom schwachen Diagnostikgeschäft in China gebremst. Der DAX-Konzern Siemens Healthineers ist mit... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| UNITEDHEALTH | 232,15 | -0,77 % | Märkte am Morgen: Bitcoin rauscht ab - Gold, Silber, Strategy, Amazon, UnitedHealth, SAP, Bayer | Der DAX kommt weiter nicht in die Gänge. Gestern startete der Leitindex zwar ordentlich, rutschte dann aber deutlich ab. Immerhin reduzierte er seine Verluste kurz vor Handelsende etwas. Heute deuten... ► Artikel lesen | |
| MEDTRONIC | 86,88 | -0,17 % | AKTIONÄR-Tipp Medtronic: Übernahme | Viel Bewegung an der Börse: Bei zahlreichen Wachstumstiteln wurden in den zurückliegenden Tagen teils deutlich Gewinne vom Tisch genommen. Der Fokus der Anleger richtet sich zusehends wieder auf defensivere... ► Artikel lesen | |
| INTUITIVE SURGICAL | 413,35 | +0,02 % | INTUITIVE SURGICAL INC - 10-K, Annual Report | ||
| THERMO FISHER | 460,70 | +0,35 % | Thermo Fisher to Close Franklin, Mass. Site, Cut Up to 80 Jobs | ||
| TELADOC HEALTH | 4,240 | -0,05 % | Teladoc Health, Inc.: Teladoc Health to Announce Fourth Quarter 2025 Financial Results | ||
| HIMS & HERS HEALTH | 19,500 | +0,15 % | Frontalangriff: Hatte Novo das auf der Rechnung? Hims kontert mit billiger Pillen-Variante! | © Foto: DALL-EWährend die Aktien von Hims mit einem zweistelligen Plus in den Handelstag startet, muss Novo Nordisk erneut kräftig Federn lassen. Die US-Pharmaplattform startet den Verkauf einer deutlich... ► Artikel lesen | |
| BICO GROUP | 1,594 | -0,25 % | BICO Group AB: BICO company Biosero launches GoSimple, a standardized automation-ready workcell with selected instruments from Sartorius and Becton, Dickinson and Company (BD) | Biosero, part of the BICO Group and a leader in lab automation, will launch the GoSimple workcell at SLAS 2026 (February 7-11, Boston, US). GoSimple is a standardized, automation-ready workcell designed... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 68,26 | -0,23 % | Eurofins Scientific SE: Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be... ► Artikel lesen | |
| BECTON DICKINSON | 176,50 | -0,70 % | Becton, Dickinson Q1 2026 Earnings Preview | ||
| ALIGN TECHNOLOGY | 158,00 | -0,47 % | Align Technology Inc. Announces Increase In Q4 Bottom Line | WASHINGTON (dpa-AFX) - Align Technology Inc. (ALGN) reported a profit for its fourth quarter that Increases, from last yearThe company's earnings came in at $135.76 million, or $1.89 per share.... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,019 | +7,87 % | NuGen Medical Devices Inc.: NuGen Medical Devices Inc. Provides Update on Health Canada License | Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse... ► Artikel lesen | |
| INMODE | 12,705 | -0,47 % | InMode gains as it evaluates strategic alternatives |